Trial Details
COMPLETEDBasic Information
| Clinical ID | c1326 |
|---|---|
| Identifier | NCT03123120 |
| Trial Title | A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Spesolimab|DRUG: Placebo |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Aalborg |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-06-07 |
|---|---|
| Primary Completion Date | 2020-03-26 |
| Completion Date | 2020-09-16 |